China'’s biotech unicorns are chasing after a huge reward. Landing it might show evasive. BeiGene Ltd.
0;$903 million in a secondary listing in Hong Kong recently. The business &#x 2019; s market price has actually swelled to $9.4 billion given that its 2016 going public on the Nasdaq, in spite of the […]